Ionis Pharmaceuticals, Inc. (IONS) Free cash flow 2016–2025
Ionis Pharmaceuticals, Inc. (IONS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$320.0MFY2025 · since FY2016: -$119.2M → -$320.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$320.0M | +41.4% |
| FY2024 | -$546.2M | -64.9% |
| FY2023 | -$331.3M | -14.2% |
| FY2022 | -$290.1M | -1639.4% |
| FY2021 | $18.8M | +2340.9% |
| FY2020 | $772,000 | -99.8% |
| FY2019 | $314.7M | -46.6% |
| FY2018 | $589.3M | +322.8% |
| FY2017 | $139.4M | +216.9% |
| FY2016 | -$119.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice